Trials / Conditions / Metastatic Thyroid Cancer
Metastatic Thyroid Cancer
5 registered clinical trials studyying Metastatic Thyroid Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC NCT05668962 | Massachusetts General Hospital | Phase 2 |
| Terminated | Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carci NCT03753919 | Grupo Espanol de Tumores Neuroendocrinos | Phase 2 |
| Unknown | Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition NCT04619316 | University Hospital, Essen | Phase 2 |
| Recruiting | Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer NCT03099356 | University of Michigan Rogel Cancer Center | Phase 2 |
| Withdrawn | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglo NCT02390739 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |